微生物组和生殖尿道癌症:一个新的前沿
Timothy B Winslow1, Sophia Gupta1, Vedha Sai Vaddaraju1
1Wilmot Cancer Institute, University of Rochester, Rochester, NY 14642, USA.
Cancers
|November 27, 2025
概括
肠道微生物组影响癌症治疗. 修改微生物组可能会提高免疫疗法的有效性,对于尿路细胞和细胞癌患者,这些患者对当前的疗法有抗性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 免疫检查点抑制剂和向药物改善了尿路细胞和细胞癌的治疗结果.
- 很大一部分患者表现出对这些治疗方法的耐药性,需要新的治疗策略.
研究的目的:
- 审查微生物群在癌症免疫力中的作用.
- 探索微生物组在增强免疫疗法反应方面的潜力.
- 讨论对尿路细胞和细胞癌治疗的影响.
主要方法:
- 关于微生物组研究近期进展的文献综述.
- 对微生物组与免疫治疗相互作用的分析.
- 探索微生物组修饰策略的探索.
主要成果:
- 微生物组动态调节免疫系统.
- 微生物组的组成会影响免疫疗法的疗效.
- 新兴的战略重点是微生物组调制,以提高治疗反应.
结论:
- 微生物组是克服尿路细胞癌和细胞癌治疗耐药性的有希望的目标.
- 未来的研究应该专注于基于微生物组的干预措施,以改善患者的治疗结果.
相关概念视频
Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Urinary Tract Infection II: Pathophysiology
542
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
542
Nursing Assessment of the Genitourinary System I: Health History
360
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
360
Urinary Tract Infection I: Introduction
518
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
518
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
236
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
236
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
354
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
354


